Lung transplant patients may bleed less during biopsies with simple drug
NCT ID NCT06422273
First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This study tests if giving tranexamic acid (a drug that helps blood clot) directly into the lungs before a biopsy can lower bleeding risk in lung transplant recipients. About 94 adults who have had a lung transplant will be randomly assigned to receive either the drug or a saltwater placebo. The goal is to see if the drug makes the procedure safer and faster.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPLICATIONS SURGICAL are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Corewell Health West
Grand Rapids, Michigan, 49503, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fewer heart scans during lung transplant may ease swallowing after surgery
- Could a simple neck band protect transplanted lungs from stomach acid?
- Lung transplant showdown: which surgical method wins?
- New registry aims to boost lung transplants by reconditioning donor lungs
- New drug trial aims to rescue failing lungs after transplant
- New hope for lung transplant patients: drug may block dangerous virus